B. Riley FBR Maintains Buy on Intercept Pharmaceuticals, Raises Price Target to $158

B. Riley FBR maintains Intercept Pharmaceuticals (NASDAQ:ICPT) with a Buy and raises the price target from $133 to $158.

Benzinga · 01/09/2020 18:50

B. Riley FBR maintains Intercept Pharmaceuticals (NASDAQ:ICPT) with a Buy and raises the price target from $133 to $158.